1999
DOI: 10.1248/cpb.47.1141
|View full text |Cite
|
Sign up to set email alerts
|

Amino Acids and Peptides. LIII. Synthesis and Biological Activities of Some Pseudo-Peptide Analogs of PKSI-527, a Plasma Kallikrein Selective Inhibitor. The Importance of the Peptide Backbone.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
7
0

Year Published

2013
2013
2018
2018

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 1 publication
1
7
0
Order By: Relevance
“…Additional controls showed that DS-induced hydrolysis was inhibited by the kallikrein inhibitor trans-4-aminomethylcy-clohexanecarbonyl-L-phenylalanyl–4-aminopheny l acetic acid (PKSI-527). 29 We did not detect significant hydrolysis in FXII-deficient plasma treated with DS (data not shown). Together, these results suggest that PdSP15a is able to attenuate contact phase activation by DS in plasma.…”
Section: Resultsmentioning
confidence: 73%
“…Additional controls showed that DS-induced hydrolysis was inhibited by the kallikrein inhibitor trans-4-aminomethylcy-clohexanecarbonyl-L-phenylalanyl–4-aminopheny l acetic acid (PKSI-527). 29 We did not detect significant hydrolysis in FXII-deficient plasma treated with DS (data not shown). Together, these results suggest that PdSP15a is able to attenuate contact phase activation by DS in plasma.…”
Section: Resultsmentioning
confidence: 73%
“…The reaction was carried out in PBS, pH 7.4, using citrated human plasma 1 : 20, 4  μ M of the Abz-peptidyl-EDDnp substrate and 20 nM of the contact system activator DXS (500 kDa). As internal controls, the plasma was pretreated with the synthetic PKa inhibitor (PKSI-527—5  μ M) [38]. Assays with recombinant ISP-2 (kindly supplied by A. P. C. A. Lima) were performed at final concentrations of 142, 177, 240, and 355 nM; the neutrophil elastase (NE) inhibitor MeOSuc-AAPV-CMK (Calbiochem) was tested at 10, 20, and 30  μ M. PKSI or recombinant ISP2 and MeOSuc-AAPV-CMK were preincubated with human plasma for 15 min, at 37°C, prior to the addition of DXS and the substrate.…”
Section: Methodsmentioning
confidence: 99%
“…Regarding antibacterial activities, it can be clearly observed that compounds 6a, 6b, 7d, 8b, 10 and 11 were the highly active compounds. 13 C NMR spectra were run in DMSO-d6 on Jeol 500 MHz ( 1 H) and 125 MHz ( 13 C) instruments. Mass spectra were run on a MAT Finnigan SSQ 7000 spectrometer, using the Electron Impact technique (EI).…”
Section: Chemistrymentioning
confidence: 99%
“…Also, some pyridinecarboxamide analogs were designed and used as PARP-1 inhibitors [10], mycobacterium tuberculosis agents [11] and as CB2 cannabinoid receptor partial agonists [12]. On the other hand, In addition, heterocyclic compounds containing an amino acid or a peptide structural moiety showed biological [13] and antibacterial activities [14]. A branched-chain amino acid (BCAA: Leu, Ile, and Val) mixture has been used for treatment of hypoalbuminemia in patients with decompensated liver cirrhosis in Japan [15].…”
Section: Introductionmentioning
confidence: 99%